Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trazodone for antidepressant-associated insomnia

A A Nierenberg1, L A Adler, E Peselow

  • 1Psychiatry Service, New York Department of Veterans Affairs Medical Center.

The American Journal of Psychiatry
|July 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine.

Journal of affective disorders·2019
Same author

Face and predictive validity of the ClockΔ19 mouse as an animal model for bipolar disorder: a systematic review.

Molecular psychiatry·2017
Same author

Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study.

Acta psychiatrica Scandinavica·2017
Same author

Physical Exercise for Treatment of Mood Disorders: A Critical Review.

Current behavioral neuroscience reports·2017
Same author

Predictive analytics in mental health: applications, guidelines, challenges and perspectives.

Molecular psychiatry·2016
Same author

Bipolar disorder: multiple pathways to neuroprogression.

Acta psychiatrica Scandinavica·2016

Trazodone effectively treats insomnia in depressed patients taking antidepressants like fluoxetine or bupropion. This study found trazodone improved sleep quality and duration for most participants, unlike placebo.

Area of Science:

  • Psychiatry
  • Sleep Medicine
  • Pharmacology

Background:

  • Insomnia is a common side effect of antidepressants such as fluoxetine and bupropion.
  • Managing antidepressant-associated insomnia is crucial for treatment adherence and patient well-being.

Purpose of the Study:

  • To evaluate the efficacy of trazodone as a hypnotic agent in depressed patients experiencing insomnia while on fluoxetine or bupropion.
  • To assess the impact of trazodone on various sleep parameters compared to placebo.

Main Methods:

  • A double-blind, placebo-controlled crossover trial involving 17 depressed patients with antidepressant-associated insomnia.
  • Sleep quality and specific sleep parameters were measured using the Pittsburgh Sleep Quality Index and the Yale-New Haven Hospital Depressive Symptom Inventory.

Related Experiment Videos

Main Results:

  • Trazodone significantly improved overall sleep quality, sleep duration, and reduced early morning awakenings compared to placebo.
  • A trend towards improvement was observed in sleep latency and middle-of-the-night awakenings.
  • 67% of completers reported overall sleep improvement with trazodone, versus 13% with placebo. Daytime sedation was a reported side effect.

Conclusions:

  • Trazodone demonstrates efficacy as a hypnotic for managing insomnia in patients treated with fluoxetine or bupropion.
  • Trazodone offers a viable treatment option for antidepressant-induced sleep disturbances.
  • Further research may explore optimal dosing to mitigate side effects like sedation.